FDA daily

FDA daily for Friday, July 17, 2026

In this issue: 11 approvals, 30 device recalls and 68 label changes. 4 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Fri, Jul 10 FDA approved 3 new applications (1 brand or biologic, 2 generic) and 8 supplements to existing ones.

  • ZYOGREEN

    PROVEPHARM SAS · INDOCYANINE GREEN

    NDA218579Drug (NDA)Prescription
  • RILPIVIRINE HYDROCHLORIDE

    LAURUS · RILPIVIRINE HYDROCHLORIDE

    ANDA219788Generic (ANDA)Prescription
  • ILOPROST

    REGCON HOLDINGS · ILOPROST

    ANDA214997Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 30 device recalls from 7 firms on Fri, Jul 10.

Browse device recalls in FDA data →

Label updates

FDA date:

68 drug labels took effect on Fri, Jul 3; 1 of the 25 read for this issue is for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

  • MDP PEPTIDE 9 BIO SUN PRO

    HOMOSALATE, OCTOCRYLENE, ETHYLHEXYL SALICYLATE, BUTYL METHOXYDIBENZOYLMETHANE · SKINIDEA CO., LTD · TOPICAL

    Healing & recovery peptidesHUMAN OTC DRUG
  • TRAZODONE HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Ibuprofen

    IBUPROFEN · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Fluoxetine

    FLUOXETINE HYDROCHLORIDE · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Lisinopril

    LISINOPRIL · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Glyburide and Metformin Hydrochloride

    GLYBURIDE AND METFORMIN HYDROCHLORIDE · Rising Pharma Holdings, Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Clonazepam

    CLONAZEPAM · REMEDYREPACK INC. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
Browse label updates in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.